Senesco Technologies, Inc. (SNT), BioCorp Ventures LLC Enter R&D Agreement to Expand Cancer Therapeutics Technology into Biofuels
BioCorp Ventures, a division of technology incubator US Equity Holdings, and Senesco Technologies today announced that they have entered into a research and development agreement regarding the use of Senesco's proprietary Factor 5A (eIF5A) technology platform for sustainable energy applications. The companies will continue ongoing research and development as BCV works on commercializing the technology. While its internal focus is cancer therapeutics, Senesco is seeking avenues to expand its technology into biofuels. Per the agreement, newly formed BCV is licensed to evaluate Senesco's technology for the development of plants and plant products suitable for use in the production of biofuel…